Renaissance Technologies’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.28M | Sell |
|
|||||
|
2025
Q1 | $28.2M | Sell |
|
|||||
|
2024
Q4 | $49.6M | Buy |
|
|||||
|
2024
Q3 | $9.44M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $9.94M | Sell |
|
|||||
|
2023
Q2 | $18.2M | Sell |
|
|||||
|
2023
Q1 | $42.5M | Buy |
|
|||||
|
2022
Q4 | $1.33M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $471K | Buy |
|
|||||
|
2021
Q4 | $203K | Sell |
|
|||||
|
2021
Q3 | $1.36M | Sell |
|
|||||
|
2021
Q2 | $5.16M | Buy |
|
|||||
|
2021
Q1 | $4.01M | Buy |
|
|||||
|
2020
Q4 | $3.78M | Buy |
|
|||||
|
2020
Q3 | $2.59M | Sell |
|
|||||
|
2020
Q2 | $8.2M | Buy |
|
|||||
|
2020
Q1 | $1.77M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $8.04M | Sell |
|
|||||
|
2017
Q3 | $5.72M | Buy |
|
|||||
|
2017
Q2 | $1.23M | Buy |
|
|||||
|
2017
Q1 | $891K | Buy |
|
|||||
|
2016
Q4 | $856K | Buy |
|
|||||
|
2016
Q3 | $672K | Sell |
|
|||||
|
2016
Q2 | $512K | Sell |
|
|||||
|
2016
Q1 | $560K | Sell |
|
|||||
|
2015
Q4 | $881K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $1.27M | Buy |
|
|||||
|
2014
Q4 | $1.7M | Buy |
|
|||||
|
2014
Q3 | $1.14M | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $1.12M | Buy |
|